Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veltassa Post-Marketing Surveillance Study in Japan
jRCT2031250353Recruiting
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Jul 2026
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of patiromer in hyperkalemia, sponsored by Zeria Pharmaceutical Co., Ltd. Primary endpoint: Safety. Started Jul 2026; status: recruiting.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on jRCT2031250353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250353.